Our results from cancer cell migration and invasion assays as well as lung metastasis models clearly showed that GLS2 inhibited metastasis of different human HCC cells, which strongly suggests that decreased expression of GLS2 in human HCC could be an important mechanism contributing to the high metastasis of human HCC. This evidence concerns the gene GLS2 and cancer.